v3.25.2
INCOME TAXES - Schedule of Components of Company's Deferred Income Tax Assets and Liabilities (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Deferred tax assets:    
Net operating loss carryforward $ 16,979,615 $ 13,095,540
Research and development credits 1,310,860 1,647,502
Capitalized pre-business expenses 3,860,144 2,229,904
Accrued expenses 219,423 124,458
Stock-based compensation 1,019,432 899,453
Inventory reserve 282,905 243,070
Operating lease liability 57,817 127,116
Capitalized 174 research and development costs 1,966,559 1,905,522
Unrealized derivative gain/loss 34,368  
Total deferred tax assets before valuation allowance 25,731,123 20,272,565
Less valuation allowance (25,386,669) (19,756,671)
Total deferred tax assets 344,454 515,894
Deferred tax liabilities    
Fixed assets (295,152) (390,191)
Right-of-use assets (49,302) (125,703)
Total deferred tax liabilities (344,454) (515,894)
Net deferred tax asset (liability) $ 0 $ 0